Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class ASSE: 600329

Report for Q1 2025

Apr 30, 2025 · Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A via Shanghai Stock Exchange

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment